Study of Cytoreduction, Gastrectomy, & Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

2016-09-07 16:23:21 | BioPortfolio


The goal of this clinical research study is to learn whether cytoreduction surgery (surgery to reduce or remove lesions), gastrectomy (where all or part of the stomach is removed), and hyperthermic intraperitoneal chemoperfusion (HIPEC, a heated chemotherapy treatment delivered directly inside the abdomen during surgery) can help control the disease in patients with gastric and/or gastroesophageal cancer. The safety of these procedures will also be studied.


Study Procedures:

If they are eligible and agree to take part, participants will have the following procedures:

- Standard-of-care cytoreduction surgery

- Standard-of-care gastrectomy

- HIPEC treatment during surgery, where they will receive mitomycin and cisplatin over about 60 minutes. HIPEC treatment surgery means they will receive mitomycin and cisplatin over about 60 minutes. Heated mitomycin and cisplatin will be delivered through plastic tubing that is connected to a pump into the abdominal cavity. The pump pushes the heated mitomycin and cisplatin into the abdominal cavity and then pulls it out and recirculates the mitomycin and cisplatin. The skin of the abdominal cavity is temporarily closed during the abdominal wash. A pump will be used to pump the heated mitomycin and cisplatin in and out of the abdominal cavity over 60 minutes while the surgeon gently presses on the abdominal wall so the mitomycin and cisplatin reaches all areas in the abdominal cavity. After 60 minutes, the mitomycin and cisplatin is removed and the abdominal cavity will be washed. The remaining fluid will be removed before the surgeon permanently closes the abdominal cavity with stitches.

- They will also receive sodium thiosulfate to help protect the kidneys and lower the risk of side effects from cisplatin.

They will sign separate consents for the cytoreduction and the gastrectomy that will explain what is done and the risks involved.

Length of Study Participation:

Their active participation in this study will be over after their surgery.

Follow Up:

Within 4 weeks after their surgery and again every 6 months after that, they will visit the clinic or be called on the phone. They will be asked how they are feeling and if they are having any problems. If they are called, these calls should last about 5 minutes.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Gastroesophageal Cancer


Hyperthermic intraperitoneal chemoperfusion (HIPEC), Sodium thiosulfate


The University of Texas MD Anderson Cancer Center
United States




M.D. Anderson Cancer Center

Results (where available)

View Results


Published on BioPortfolio: 2016-09-07T16:23:21-0400

Clinical Trials [1426 Associated Clinical Trials listed on BioPortfolio]

Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

The goal of this clinical research study is to find the highest tolerable dose of paclitaxel that can be given as hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with gastric...

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

This study is designed to evaluate the efficacy and safety of adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed or oxaliplatin versus no HIPEC in locally advanced...

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

The OvIP1 study is designed to examine how drug dose and perfusion temperature affect the pharmacokinetics and pharmacodynamics of cisplatin used as (hyperthermic) intraperitoneal chemoper...

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)

This is a phase III, multicenter, interventional and randomized study which evaluates the use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) coupled with either Primary Debulking Sur...

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer

This is a phase II open label, single arm clinical trial on safety and efficacy exploring an short-course regimen of intra-operative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as up...

PubMed Articles [15757 Associated PubMed Articles listed on BioPortfolio]

Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.

We hypothesized that repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC) for peritoneal metastases (PM) may be associated with suboptimal resection, more frequent post...

Is it the right moment to include hyperthermic intraperitoneal chemotherapy as standard in ovarian cancer management? A reappraisal.

Ovarian cancer is a leading cause of cancer-related death in women and often is diagnosed at an advanced stage with diffuse peritoneal carcinomatosis. Since it is mainly confined to the peritoneal cav...

Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?

The purpose of this study was to assess the feasibility and safety of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in elderly patients with peritoneal carcinomatos...

RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.

Metastatic colorectal cancer (mCRC) with peritoneal carcinomatosis is an increasingly prevalent disease that carries significant mortality if left untreated. Cytoreductive surgery with hyperthermic in...

Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP Analysis.

Formal gastrectomy is occasionally required to achieve complete cytoreduction for patients with peritoneal surface malignancies. In addition, the role of cytoreductive surgery (CRS) and hyperthermic i...

Medical and Biotech [MESH] Definitions

A sodium salt of gold thiosulfate. It has uses like the ORGANOGOLD COMPOUNDS.

An enzyme that catalyzes the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion. EC

Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate.

A voltage-gated sodium channel subtype that mediates the sodium ion PERMEABILITY of CARDIOMYOCYTES. Defects in the SCN5A gene, which codes for the alpha subunit of this sodium channel, are associated with a variety of CARDIAC DISEASES that result from loss of sodium channel function.

Stable sodium atoms that have the same atomic number as the element sodium, but differ in atomic weight. Na-23 is a stable sodium isotope.

More From BioPortfolio on "Study of Cytoreduction, Gastrectomy, & Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology"

Quick Search


Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Searches Linking to this Trial